Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New bifunctional piperidinamide derivative as sigma-1 and mu-opioid receptor agonist

Dec. 9, 2021

Edgewise Therapeutics patents myosin inhibitors

Dec. 9, 2021

Shanghai Meiyue Biotech Development describes new coagulation factor XIa inhibitors

Dec. 9, 2021

Bsense reports preclinical data on BSEN-627 in rat pain model

Dec. 7, 2021

Alpha Cognition reports preclinical data from ALPHA-1062 intranasal TBI program

Dec. 7, 2021

ED to AD: Viagra associated with lower risk of Alzheimer's disease

Dec. 7, 2021

Gfap-targeted ASO therapy shows efficacy in rat model of Alexander disease

Dec. 7, 2021

SRI-42127 attenuates glial activation in a model of LPS-induced neuroinflammation

Dec. 7, 2021

Novel selective c-Abl inhibitor prevents neurodegeneration in models of Parkinson's

Dec. 3, 2021

HCN targeting rescues chronic stress-induced cognitive deficits

Dec. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...